Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Related Citations for PubMed (Select 22336156)

1.

[Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].

Yang GZ, Zhang XL, Li J, Ding HY.

Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):741-4. Chinese.

PMID:
22336156
3.

[Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].

Li L, Bi XF, Xu X, Liu XY, Shen GH, Guo L, Yuan YL, Wang F, Wang MR, Yang HY.

Zhonghua Zhong Liu Za Zhi. 2010 Apr;32(4):273-7. Chinese.

PMID:
20510078
4.

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.

Am J Clin Pathol. 2001 Jan;115(1):85-98.

5.

The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.

Dabbs DJ, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter GJ.

Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):260-6.

PMID:
17721269
6.

Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.

Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM.

Am J Clin Pathol. 2000 Aug;114(2):190-6.

7.

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM.

J Pathol. 1997 Dec;183(4):404-11.

PMID:
9496256
8.

Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.

Choi YJ, Pinto MM, Hao L, Riba AK.

Mod Pathol. 2008 Oct;21(10):1224-37. doi: 10.1038/modpathol.2008.106. Epub 2008 Jun 27.

9.

[Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].

Chipysheva TA, Ermilova VD, Vishnevskaia IaV, Vasil'ev IuM.

Arkh Patol. 2005 Nov-Dec;67(6):24-7. Russian.

PMID:
16405017
10.

E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.

Wahed A, Connelly J, Reese T.

Ann Diagn Pathol. 2002 Dec;6(6):349-51.

PMID:
12478484
11.

[Invasive lobular carcinoma of basal-like subtype of breast: a clinicopathologic analysis].

Zhang LY, Gao LX, Liu G, Yang GZ, Cheng J, Ding HY.

Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):599-603. Chinese.

PMID:
24314245
12.

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

Rakha EA, Patel A, Powe DG, Benhasouna A, Green AR, Lambros MB, Reis-Filho JS, Ellis IO.

Am J Surg Pathol. 2010 Oct;34(10):1472-9. doi: 10.1097/PAS.0b013e3181f01916.

PMID:
20871222
14.

[E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].

Han A, Xiong M, Li Z, Liang Y.

Zhonghua Bing Li Xue Za Zhi. 2001 Feb;30(1):27-30. Chinese.

PMID:
11866953
15.

Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.

Dabbs DJ, Bhargava R, Chivukula M.

Am J Surg Pathol. 2007 Mar;31(3):427-37.

PMID:
17325485
16.

Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.

Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Lakhani SR, Palacios J, Rakha E, Richardson AL, Schmitt FC, Tan PH, Tse GM, Vincent-Salomon A, Ellis IO, Badve S, Reis-Filho JS.

Am J Surg Pathol. 2013 Jul;37(7):e1-11. doi: 10.1097/PAS.0b013e3182918a2b. Review.

PMID:
23759937
17.

Aberrant expression of E-cadherin in lobular carcinomas of the breast.

Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT.

Am J Surg Pathol. 2008 May;32(5):773-83. doi: 10.1097/PAS.0b013e318158d6c5.

PMID:
18379416
18.

[Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast].

Yin HF, Li T, Zhang H, Zhang S.

Zhonghua Bing Li Xue Za Zhi. 2009 Oct;38(10):663-7. Chinese.

PMID:
20078969
19.

[Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer].

García Tamayo J, Blasco Olaetxea E, Morales A, Molina J, Guzmán Bistoni C, Méndez V.

Invest Clin. 2006 Dec;47(4):371-83. Spanish.

PMID:
17176905
20.

Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.

Rakha EA, Teoh TK, Lee AH, Nolan CC, Ellis IO, Green AR.

Histopathology. 2013 Apr;62(5):695-701. doi: 10.1111/his.12066. Epub 2013 Jan 24.

PMID:
23347178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk